Dr. Nassim Beiranvand joined the Texas Medical Center (TMCi) team as a Computational Chemist. She is a Ph.D.-trained computational chemist with extensive experience in biotech and startup companies, specializing in accelerating small molecule drug discovery. Her expertise in cutting-edge computational techniques has played a pivotal role in the identification and optimization of novel therapeutics.

Dr. Beiranvand has a strong background in both structure-based and ligand-based drug design and is proficient in high-throughput methods for virtual screening, including molecular docking, pharmacophore modeling, electrostatic shape matching, free energy calculations (FEP and MM-GBSA), QSAR, and shape similarity. In addition, she has deep expertise in quantum chemistry and protein modeling, making her well-versed in a wide array of computational tools for drug design.

Passionate about leveraging advanced computational approaches to drive drug discovery, Dr. Beiranvand excels in interdisciplinary collaboration and data-driven decision-making. Her innovative work has also contributed to the development of AI-enhanced lipid nanoparticle design platforms.